|
PRC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.70190553159E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.008490E-04 |
| Normal-vs-Stage2 |
9.470300E-02 |
| Normal-vs-Stage3 |
2.45169999999462E-05 |
| Normal-vs-Stage4 |
9.378200E-03 |
| Stage1-vs-Stage2 |
5.415000E-01 |
| Stage1-vs-Stage3 |
9.580400E-04 |
| Stage1-vs-Stage4 |
3.335500E-02 |
| Stage2-vs-Stage3 |
4.622000E-02 |
| Stage2-vs-Stage4 |
7.701900E-02 |
| Stage3-vs-Stage4 |
7.944800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.51750012134767E-10 |
| Normal-vs-AfricanAmerican |
7.829600E-04 |
| Normal-vs-Asian |
1.482100E-02 |
| Caucasian-vs-AfricanAmerican |
9.883800E-01 |
| Caucasian-vs-Asian |
2.726000E-01 |
| AfricanAmerican-vs-Asian |
3.079200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.21119999982622E-08 |
| Normal-vs-Female |
2.12040000002744E-07 |
| Male-vs-Female |
2.603500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.036000E-04 |
| Normal-vs-Extreme_Weight |
1.153740E-04 |
| Normal-vs-Obese |
1.55778999999523E-05 |
| Normal-vs-Extreme_Obese |
5.037200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.303700E-02 |
| Normal_Weight-vs-Obese |
8.675600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.560300E-03 |
| Extreme_Weight-vs-Obese |
2.242300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.253700E-02 |
| Obese-vs-Extreme_Obese |
6.161400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.857500E-03 |
| Normal-vs-Age(41-60Yrs) |
1.39510003549503E-09 |
| Normal-vs-Age(61-80Yrs) |
1.426920E-04 |
| Normal-vs-Age(81-100Yrs) |
3.203900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.997900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.199800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.447910E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.266400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.091700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.331000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.59630999999605E-05 |
| Normal-VS-Type2 PRCC |
4.42379999999742E-05 |
| Normal-VS-KIRP CIMP |
5.159500E-04 |
| Normal-VS-Unclassified PRCC |
4.224500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.323830E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.137550E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.128100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.024200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.370800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.261400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.418740E-03 |
| Normal-vs-N1 |
2.01199999999568E-05 |
| Normal-vs-N2 |
1.512600E-01 |
| N0-vs-N1 |
6.561400E-04 |
| N0-vs-N2 |
3.101900E-02 |
| N1-vs-N2 |
7.449200E-01 |
|
|
